ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Incidence and Effects of Posttransplant Herpes Zoster in Adult Solid Organ Transplant Recipients : A Meta-Analysis

    S. H. Han, D. Kwon

    Yonsei University Health System, Seoul, Korea, Republic of

    *Purpose: Recently, non-live recombinant subunit HZ vaccine showed highly effective for herpes zoster (HZ) in hematopoietic stem cell transplantation. Several observational studies reported various features…
  • 2020 American Transplant Congress

    Evaluation of Cytomegalovirus Prophylaxis in Low and Intermediate Risk Kidney Transplant Recipients Receiving Lymphocyte-Depleting Induction

    H. Stamps, K. Linder, D. O'Sullivan, F. Cheema, H. Kutzler

    Hartford Hospital, Hartford, CT

    *Purpose: This study evaluates if choice and duration of Cytomegalovirus (CMV) prophylaxis based on donor (D) and recipient (R) CMV serostatus impacts the incidence of…
  • 2020 American Transplant Congress

    Impact of Organ Donor Infections on Kidney Transplant Recipient Outcomes

    M. Santarossa1, C. Muran2, S. Sanchez2, L. Heinrich2, J. Yoo3, F. Albarillo1, S. Akkina3, N. Clark1, G. Reid1

    1Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, 2Department of Pharmacy, Loyola University Medical Center, Maywood, IL, 3Department of Medicine, Division of Transplant Nephrology, Loyola University Medical Center, Maywood, IL

    *Purpose: Donor-derived infections can lead to significant morbidity and mortality in organ transplant recipients. There is variability by center on treatment of positive donor cultures…
  • 2020 American Transplant Congress

    Incidence and Outcomes of Secondary Cutaneous Malignancies among Renal Transplant Recipients

    T. Maw1, P. Vaidya1, J. Samaan2, S. Ghanshani1, G. In1

    1Keck School of Medicine, LA, CA, 2Cedar Sinai Hospital, LA, CA

    *Purpose: Solid-organ transplant recipients on immunosuppressive therapy are known to have higher morbidity and mortality from secondary malignancies; however, there are no established guidelines for…
  • 2020 American Transplant Congress

    Transplantation from Donors with Positive Blood Culture

    H. Mo, S. Min, H. Ko, C. Chung, H. Kim, A. Han, J. Ha

    Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of

    *Purpose: The use of organs from donors with infection is limited because of the possibility of transmission. Herein we report our experience of transplantation from…
  • 2020 American Transplant Congress

    Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients

    S. J. Yusuf1, H. Bheemreddy1, A. Imtiaz2, N. Krishnan3

    1Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom, 2Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, 3Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

    *Purpose: Over the years there has been a shift in the use of anti-metabolites agents from azathioprine to mycophenolate mofetil (MMF) based immunosuppression., due to…
  • 2020 American Transplant Congress

    A Comprehensive Evaluation of Risk Factors for Pneumocystis Jiroveci Pneumonia in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

    N. Permpalung1, V. Kittipibul2, P. Mekraksakit3, P. Rattanawong4, S. Nematollahi1, S. Mehta-Steinke1

    1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Miami/Jackson Memorial Hospital, Miami, FL, 3Texas Tech University Health Sciences, Lubbock, TX, 4Mayo Clinic, Phoenix, AZ

    *Purpose: Pneumocytis jiroveci pneumonia (PJP) is an important opportunistic fungal infection in solid organ transplant (SOT) recipients that carries a significant morbidity and mortality. Several…
  • 2020 American Transplant Congress

    Real-World Experiences in the Transplantation of Hepatitis C Positive Kidneys

    J. M. Steinbrink, J. Byrns, L. Crona, M. Ellis, S. Sanoff, E. K. Maziarz, C. R. Wolfe

    Duke University, Durham, NC

    *Purpose: With advancements of direct-acting antivirals, transplantation of HCV-NAT+ (HCV+) organs to HCV-negative (HCV-) recipients has been used to decrease wait times without apparent sacrifice…
  • 2020 American Transplant Congress

    Viral Kinetics of De Novo HCV Infection and Response to Antiviral Therapy in Liver and Kidney Transplant Recipients Receiving HCV-Viremic Donors

    N. Terrault1, J. Burton2, E. Verna3, C. Mobley4, D. Victor4, J. Trotter5, C. Niemann6, R. Rubin7

    1University of Southern California, Los Angeles, CA, 2UC, Denver, CO, 3Columbia Universeity, New York, NY, 4Houston Methodist, Houston, TX, 5Baylor University, Dallas, TX, 6UCSF, San Francisco, CA, 7Piedmont Atlanta Hosptial, Atlanta, GA

    *Purpose: There is general agreement that expanded use of organs from HCV-viremic donors is desirable, including in recipients without HCV infection. However, the optimal treatment…
  • 2020 American Transplant Congress

    Incidence of Cytomegalovirus Infection in Deceased Donor Kidney Transplantation from Hepatitis-C Antibody Positive Donors to Hepatitis-C Antibody Negative Recipients: A National Registry Analysis

    M. Yazawa1, T. Fülöp2, O. Cseprekal3, M. Talwar1, V. Balaraman1, A. Bhalla1, A. Azhar1, C. P. Kovesdy4, J. D. Eason1, M. Z. Molnar1

    1James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, 2Division of Nephrology, Department of Medicine, Medical University of South Carolina, South Carolina, SC, 3Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, 4Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN

    *Purpose: Deceased donor kidney transplantation (KT) from hepatitis C (HCV) infected donors into HCV uninfected recipients (HCV D+/R-) will be the standard of care in…
  • « Previous Page
  • 1
  • …
  • 359
  • 360
  • 361
  • 362
  • 363
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences